Latest filing published 28 Jun 2017 for Cartesian Therapeutics, Inc., €2,553.
Filing timeline
BuySaleInsider track record
Peter Keller: trading record in brief
Peter Keller is a declared insider of Cartesian Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 19 December 2016 and the latest from 27 June 2017.
Every open-market trade on record is a sale: 2 sales worth €162k. Besides market trades, the filings include 1 option exercise. In 2017 alone, the filings show no purchases and 1 sale.
On 28 June 2017 came the latest disclosure, an option exercise for €2,553 in Cartesian Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Keller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,595 shares@ US$0.631.5% of flowCommon StockSEC:0001638599-17-000661:0
- 4,595 shares@ US$19.299547.5% of flowCommon StockSEC:0001638599-17-000661:1
- 4,723 shares@ US$18.5851.0% of flowCommon StockSEC:0001104659-16-163295:0
3 of 3 declarations
